Reply to 'NALIRIFOX in the frontline for metastatic pancreatic cancer: evidence beyond NAPOLI 3'.
作者信息
Nevala-Plagemann Christopher, Conroy Thierry, Garrido-Laguna Ignacio
机构信息
Division of Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Department of Medical Oncology, Institut de Cancérologie de Lorraine, Vandoeuvre-lès-Nancy, France.
出版信息
Nat Rev Clin Oncol. 2024 Dec;21(12):902. doi: 10.1038/s41571-024-00953-4.
PMID:39455871
Abstract
摘要
Zotero 插件